Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6073808 | Journal of the American Academy of Dermatology | 2013 | 13 Pages |
Abstract
Hypercoagulable states (HS) are inherited or acquired conditions that predispose an individual to venous and/or arterial thrombosis. The dermatologist can play a vital role in diagnosing a patient's HS by recognizing the associated cutaneous manifestations, such as purpura, purpura fulminans, livedo reticularis, livedo vasculopathy (atrophie blanche), anetoderma, chronic venous ulcers, and superficial venous thrombosis. The cutaneous manifestations of HS are generally nonspecific, but identification of an abnormal finding can warrant a further workup for an underlying thrombophilic disorder. This review will focus on the basic science of hemostasis, the evaluation of HS, the skin manifestations associated with hypercoagulability, and the use of antiplatelet and anticoagulant therapy in dermatology.
Keywords
SVTPurpura fulminansAPLSAPLAAPCTTPVTELMWHDICPulmonary embolismAntiphospholipid antibodyHITDIC, Disseminated intravascular coagulationVenous thromboembolismThrombotic thrombocytopenic purpuraThrombosisDVTDeep venous thrombosisSuperficial venous thrombosisHeparin-induced thrombocytopeniaHypercoagulable statesAntiphospholipid antibody syndromeTissue factorHemostasislow-molecular-weight heparinActivated protein Cpurpuralivedo reticularis
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Laura A. MD, Kristen I. MD, Joseph C. MD,